Martin William Dewhurst serves as Executive at Turn Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Martin William Dewhurst has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 7, 2026 involved receiving (via award) 21,882 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 7, 2026 | TTRX | $0 | Award | 21,882 | $N/A | Discretionary |
Martin William Dewhurst currently holds 21,882 shares of Turn Therapeutics Inc. (TTRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Martin William Dewhurst has been a net neutral trader of TTRX stock. They have purchased $0 and sold $0 worth of shares.
Martin William Dewhurst's most recent insider trade was on Jan 7, 2026, when they sold 21,882 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted